U-M Spinout Asalyxa Bio Developing Inflammatory Treatment Platform, Aiding COVID-19 Patients
August 26, 2020
August 26, 2020
ANN ARBOR, Michigan, Aug. 26 -- The University of Michigan issued the following news release:
Asalyxa Bio, a startup with neutrophil targeting drug-delivery technology invented at University of Michigan that aims to treat a wide range of inflammatory diseases, has secured seed funding to advance toward the first in-human trials next year.
Asalyxa Bio was co-founded by U-M scientists and Orange Grove Bio, a New York-based venture operating company. The company's chi . . .
Asalyxa Bio, a startup with neutrophil targeting drug-delivery technology invented at University of Michigan that aims to treat a wide range of inflammatory diseases, has secured seed funding to advance toward the first in-human trials next year.
Asalyxa Bio was co-founded by U-M scientists and Orange Grove Bio, a New York-based venture operating company. The company's chi . . .